Transcriptomics and Brain Volumetrics Define the Causes of Cognitive Impairment in Patients with CIRS and Support the use of VIP in Treatment
Main Article Content
Abstract
Problems with executive cognitive function, including recent memory, concentration, word finding, confusion, decreased assimilation, and disorientation, can have a variety of sources of disease, including inflammation, metabolic disturbances, and degenerative processes that are typically found in diseases where chronic fatigue is present. The problems presented by multiple coexisting cognitive symptoms are finding: 1) a single diagnostic test that has a history of use by clinicians working with brain-injured patients, such as NeuroQuant (NQ); 2) that is affordable, accurate, and reliable to use as a measure of benefits, or lack of same; and 3) screening, causation, and sequential features of therapy. Furthermore, the complexity of brain injury shows us the limitations of human versus machine-based testing, with advances in transcriptomics leading the way in a new world of diagnostics and therapies that follow gene activation studies.
The objective of this report was to retrospectively look at results of the transcriptomic testing of white blood cells, combined with a brain volumetric imaging study, in an observational study to provide a basis to identify the specific causation of brain injury caused by exposure to the interior environment of water-damaged buildings (WDB). By comparing transcriptomic abnormalities with known volumetric patterns of injury to cortical grey matter, enlargement of superior lateral ventricles and atrophy of grey matter nuclei, we demonstrate the feasibility of treatment of brain injury employing noninvasive methods in preparation for novel treatments previously shown to be effective. We intend to use these tests sequentially in a before-and-after fashion to show correction of metabolic and inflammatory conditions found in chronic inflammatory response syndrome (CIRS) in a subsequent study.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2Shoemaker, R, Johnson K, Jim L, Berry Y, Dooley M, Ryan J, McMahon S. Diagnostic process for Chronic Inflammatory Response Syndrome (CIRS): A Consensus Statement report of the Consensus Committee of Surviving Mold. Internal Medicine Review 2018. 4: 1-47.
3Shoemaker R, House D, Ryan J. Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health 2013; 396:401
4 Shoemaker R, McMahon S, Ryan J, et al. Intranasal VIP safely restores volume to multiple grey matter nuclei in patients with CIRS. Internal Medicine Review 2017; 1: 1-21.
5Shoemaker R. Metabolism, molecular hypometabolism and inflammation: Complications of proliferative physiology include metabolic acidosis, pulmonary hypertension, T reg cell deficiency, insulin resistance and neuronal injury. Trends in Diabetes Metab 2020; 3: 1-15.
6 Vander Heiden M, Cantely L, Thompson C. Understanding the Warburg Effect; The metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
7Shoshan V, Keinan N, Zaid H. Uncovering the role of VDAC in the regulation of cell life and death. Biochem Pharmacol 2020; 40: 183-91.
8Heslop K, Rovin A, Hunt E, Fang D, Morris M, et.al. JNK Activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. Biochem Pharmacol 2020; 171: 113728.
9 Ryan J, Shoemaker R. RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal peptide (VIP) shows a shift in metabolic state and innate immune functions that coincide with healing. Medical Research Archives, 2017, 4: 1.
10 Ryan J, Wu Q, Shoemaker R. Transcriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxin. BMC Medical Genomics 2015; 8:15.
11 Shoemaker R, Neil V, Heyman A, van der Westhuizen M, McMahon S, Lark D. Newer Molecular methods bring new insights into human and building health risk assessments from water-damaged buildings: Defining exposure and reactivity, the two sides of causation of CIRS-WDB illness. Medical Research Archives 2021; 9:
12 Jones, Williams and Bianchi, Kanisicak. Aerobic Glycolysis: Beyond Proliferation. Frontiers in Immunology. 2015; 6: 227.
13 Kawamoto M, Page E. Notes from the field; use off unvalidated urine mycotoxin tests for the clinical diagnosis of illness-US 2014. MMWR 2015;64: 157-158.
14 Shoemaker R, Lark D. Urinary mycotoxins: A review of contaminated buildings and food in search of a biomarker separating sick patients from controls. Int Med Rev 2019; 5(6): 1-35.
15 Toda M, Beer K, Kuivila K, Chiller T, Jackson B. Trends in agricultural triazole fungicide use in the United States, 1992-2016 and possible implications for anti-fungal-resistant fungi in human disease. Env Health Perspect 2021; 129::055001-1-2.
16 Rubin R. On the rise, Candida auris outwits treatments and travels incognito in health care settings. JAMA 2023; 329: 197-199.